Details for 2016154916

Up to date per 01.04.2026

Actions

Title / Product Name

ANTIKÖRPERMOLEKÜLE MIT SPEZIFITÄT FÜR MENSCHLICHEN TUMOR-NEKTROSE-FAKTOR-ALPHA SOWIE VERWENDUNG DAVON

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2016154916

EP Publication Number

3059314

E-Number

1056711

Language

PCT Number

Publication Date

24.08.2016 A

24.10.2018 B1

Registration Date

24.10.2018

AT Publication Date

15.11.2018

Application Date

05.06.2001

Registration Number

Priorities

06.06.2000

0013810

IPC

C12N 15/13 20060101AFI20171215BHEP

Maximum Duration of Protection

05.06.2021

Owner

UCB Pharma, S.A.Allée de la Recherche 60 1070 BruxellesBE

Representative

Sonn & Partner PatentanwälteRiemergasse 141010 WienAT

Inventor

Athwal, Diljeet Singhc/o Intellectual Property Dpt UCB Celltech Ltd. 208 Bath Road Slough Berkshire SL1 3WEGB

Brown, Derek Thomasc/o Intellectual Property Dpt UCB Celltech Ltd. 208 Bath Road Slough Berkshire SL1 3WEGB

Weir, Andrew Neil Charlesc/o Intellectual Property Dpt UCB Celltech Ltd. 208 Bath Road Slough Berkshire SL1 3WEGB

Popplewell, Andrew Georgec/o Intellectual Property Dpt UCB Celltech Ltd. 208 Bath Road Slough Berkshire SL1 3WEGB

Chapman, Andrew Paulc/o Intellectual Property Dpt UCB Celltech Ltd. 208 Bath Road Slough Berkshire SL1 3WEGB

King, David Johnc/o Intellectual Property Dpt UCB Celltech Ltd. 208 Bath Road Slough Berkshire SL1 3WEGB